IL117465A - Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis - Google Patents

Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis

Info

Publication number
IL117465A
IL117465A IL11746596A IL11746596A IL117465A IL 117465 A IL117465 A IL 117465A IL 11746596 A IL11746596 A IL 11746596A IL 11746596 A IL11746596 A IL 11746596A IL 117465 A IL117465 A IL 117465A
Authority
IL
Israel
Prior art keywords
restenosis
medicament
preparation
treatment
cystine derivatives
Prior art date
Application number
IL11746596A
Other languages
English (en)
Other versions
IL117465A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL117465A0 publication Critical patent/IL117465A0/xx
Publication of IL117465A publication Critical patent/IL117465A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11746596A 1995-03-14 1996-03-13 Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis IL117465A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives

Publications (2)

Publication Number Publication Date
IL117465A0 IL117465A0 (en) 1996-07-23
IL117465A true IL117465A (en) 2000-07-26

Family

ID=20397536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11746596A IL117465A (en) 1995-03-14 1996-03-13 Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis

Country Status (24)

Country Link
US (1) US5883126A (xx)
EP (1) EP0814798A1 (xx)
JP (1) JPH11501916A (xx)
KR (1) KR19980703055A (xx)
CN (1) CN1183718A (xx)
AR (1) AR002716A1 (xx)
AU (1) AU701287B2 (xx)
BR (1) BR9607225A (xx)
CA (1) CA2214831A1 (xx)
CZ (1) CZ288219B6 (xx)
EE (1) EE03382B1 (xx)
HU (1) HUP9801985A3 (xx)
IL (1) IL117465A (xx)
IS (1) IS4554A (xx)
NO (1) NO974143D0 (xx)
NZ (1) NZ303781A (xx)
PL (1) PL183234B1 (xx)
SE (1) SE9500897D0 (xx)
SK (1) SK282448B6 (xx)
TR (1) TR199700945T1 (xx)
TW (1) TW385249B (xx)
UA (1) UA42830C2 (xx)
WO (1) WO1996028149A1 (xx)
ZA (1) ZA961749B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007819A (en) * 1995-10-17 1999-12-28 Dovetail Technologies, Inc. Methods of inducing immunity using low molecular weight immune stimulants
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (xx) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
TW221376B (xx) * 1990-06-28 1994-03-01 Astra Ab
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
CA2125888C (en) * 1992-01-06 2002-08-27 Harry B. Demopoulos Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker

Also Published As

Publication number Publication date
JPH11501916A (ja) 1999-02-16
TR199700945T1 (xx) 1998-02-21
HUP9801985A3 (en) 2000-07-28
UA42830C2 (uk) 2001-11-15
WO1996028149A1 (en) 1996-09-19
IL117465A0 (en) 1996-07-23
IS4554A (is) 1997-08-27
CN1183718A (zh) 1998-06-03
BR9607225A (pt) 1998-07-07
AR002716A1 (es) 1998-04-29
CA2214831A1 (en) 1996-09-19
EE03382B1 (et) 2001-04-16
EP0814798A1 (en) 1998-01-07
HUP9801985A2 (hu) 1998-12-28
MX9706825A (es) 1997-11-29
PL183234B1 (pl) 2002-06-28
CZ280497A3 (cs) 1998-01-14
AU701287B2 (en) 1999-01-21
ZA961749B (en) 1996-09-16
US5883126A (en) 1999-03-16
SE9500897D0 (sv) 1995-03-14
AU5018596A (en) 1996-10-02
CZ288219B6 (en) 2001-05-16
NO974143L (no) 1997-09-09
KR19980703055A (ko) 1998-09-05
NZ303781A (en) 2001-03-30
PL322328A1 (en) 1998-01-19
SK282448B6 (sk) 2002-02-05
EE9700229A (et) 1998-04-15
SK120797A3 (en) 1998-02-04
NO974143D0 (no) 1997-09-09
TW385249B (en) 2000-03-21

Similar Documents

Publication Publication Date Title
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
AU4048295A (en) Peptide medicaments for the treatment of disease
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
HK1005425A1 (en) Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis
HUP9901089A3 (en) Medical splint
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
HUP9802677A3 (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU3187595A (en) Compounds for the treatment of restenosis
AU2806692A (en) Medicament for the treatment of anxiety
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
GB2303303B (en) Medical treatment
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
GB9521725D0 (en) Medical treatment
ZA95908B (en) A synergistic formulation for treatment of rheumatic diseases
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
SI0778025T1 (en) Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees